Evidence map›Paper›PMID 24705597›Full record

ArticleNature protocols2014

Targeted sequencing for gene discovery and quantification using RNA CaptureSeq.

Tim R Mercer, Michael B Clark, Joanna Crawford, Marion E Brunck, Daniel J Gerhardt, Ryan J Taft, Lars K Nielsen, Marcel E Dinger, John S Mattick

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Pathologica · 2023
    Review
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tim R Mercer1] Garvan Institute of Medical Research, Sydney, New South Wales, Australia. [2].
Michael B Clark1] Garvan Institute of Medical Research, Sydney, New South Wales, Australia. [2] Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. [3].
Joanna Crawford1] Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia. [2].
Marion E BrunckAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.
Daniel J GerhardtMater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Ryan J TaftInstitute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
Lars K NielsenAustralian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia.ORCID 0000000181913511
Marcel E DingerGarvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 000000034423934X
John S MattickGarvan Institute of Medical Research, Sydney, New South Wales, Australia.ORCID 0000000276807527

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA sequencing (RNAseq) samples the majority of expressed genes infrequently, owing to the large size, complex splicing and wide dynamic range of eukaryotic transcriptomes. This results in sparse sequencing coverage that can hinder robust isoform assembly and quantification. RNA capture sequencing (CaptureSeq) addresses this challenge by using oligonucleotide probes to capture selected genes or regions of interest for targeted sequencing. Targeted RNAseq provides enhanced coverage for sensitive gene discovery, robust transcript assembly and accurate gene quantification. Here we describe a detailed protocol for all stages of RNA CaptureSeq, from initial probe design considerations and capture of targeted genes to final assembly and quantification of captured transcripts. Initial probe design and final analysis can take less than 1 d, whereas the central experimental capture stage requires ∼7 d.

Indexed as

SoftwareExonsGenetic Association StudiesNucleic Acid Amplification TechniquesOligonucleotide ProbesSequence Analysis, RNAOligonucleotide Probes

Identifiers

PMID24705597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.